Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin.
Yannick DerwaChristopher J M WilliamsRuchit SoodSaqib MumtazM Hassan BholahChristian P SelingerP John HamlinAlexander C FordDavid J GraciePublished in: Therapeutic advances in gastroenterology (2018)
Apart from escalation of medical therapy in UC, clinical decision-making was not associated with mucosal inflammation in IBD. The use of point-of-care calprotectin testing may aid clinical decision-making, improve resource allocation and reduce costs in IBD.